[Treatment of essential hypertension].
Koichev
A
A
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004038:Diet, Reducing; D004232:Diuretics / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000628:therapy*; D012084:Renin-Angiotensin System / Q000187:drug effects; D013565:Sympatholytics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D005730:Ganglionic Blockers; D013565:Sympatholytics; D014665:Vasodilator Agents
Lechenie na khipertonichnata bolest.